Literature DB >> 24380215

Conversion of Karnofsky Performance Status (KPS) and Eastern Cooperative Oncology Group Performance Status (ECOG) to Palliative Performance Scale (PPS), and the interchangeability of PPS and KPS in prognostic tools.

Ingrid de Kock1, Mehrnoush Mirhosseini2, Francis Lau3, Vincent Thai4, Michael Downing5, Hue Quan6, Mary Lesperance7, Ju Yang3.   

Abstract

AIM: The aim of our study was to assess whether the Karnofsky Performance Status (KPS), the Eastern Cooperative Oncology Group (ECOG) Performance Status, and the Palliative Performance Scale (PPS) are interchangeable individually or within two prognostic tools: the Palliative Prognostic Score (PaP) and the Palliative Prognostic Index (PPI).
METHODS: We performed a subset analysis of a prospective comparative study of functional and prognostic tools and clinician prediction of survival. We studied 955 patients with advanced life-limiting illnesses (cancer and noncancer) in the acute care and community settings. We used a descriptive statistical model and Spearman's rank correlation to assess these interchangeabilities.
RESULTS: There is a direct positive linear relationship between the KPS and the PPS, and a direct negative linear relationship between these tools and the ECOG. Exchange of the KPS and the PPS was possible within the PaP and the PPI.
CONCLUSION: The PPS and the KPS can be used interchangeably as functional tools and within prognostic tools. The ECOG is interchangeable with the PPS and the KPS, but this interchangeability is population-specific.

Entities:  

Mesh:

Year:  2013        PMID: 24380215

Source DB:  PubMed          Journal:  J Palliat Care        ISSN: 0825-8597            Impact factor:   2.250


  29 in total

1.  A scoring system to guide the decision for a new systemic treatment after at least two lines of palliative chemotherapy for metastatic cancers: a prospective study.

Authors:  Brice Chanez; François Bertucci; Marine Gilabert; Anne Madroszyk; Frédérique Rousseau; Delphine Perrot; Patrice Viens; Jean-Luc Raoul
Journal:  Support Care Cancer       Date:  2017-03-28       Impact factor: 3.603

2.  Population description and clinical response assessment for spinal metastases: part 2 of the SPIne response assessment in Neuro-Oncology (SPINO) group report.

Authors:  Ilya Laufer; Simon S Lo; Eric L Chang; Jason Sheehan; Matthias Guckenberger; Moon-Jun Sohn; Samuel Ryu; Matthew Foote; Alexander Muacevic; Scott G Soltys; Samuel Chao; Sten Myrehaug; Peter C Gerszten; Eric Lis; Pejman Maralani; Mark Bilsky; Charles Fisher; Laurence Rhines; Jorrit-Jan Verlaan; David Schiff; Michael G Fehlings; Lijun Ma; Susan Chang; Wendy R Parulekar; Michael A Vogelbaum; Arjun Sahgal
Journal:  Neuro Oncol       Date:  2018-08-02       Impact factor: 12.300

3.  [A German version of the Palliative Performance Scale (PPS) as a supportive structure to assess survival in palliative patients].

Authors:  Veronika Mosich; Martin Andersag; Herbert Watzke
Journal:  Wien Med Wochenschr       Date:  2019-11-14

4.  Local modulated electro-hyperthermia in combination with traditional Chinese medicine vs. intraperitoneal chemoinfusion for the treatment of peritoneal carcinomatosis with malignant ascites: A phase II randomized trial.

Authors:  Clifford L K Pang; Xinting Zhang; Zhen Wang; Junwen Ou; Yimin Lu; Pengfei Chen; Changlin Zhao; Xiaopu Wang; Hongyu Zhang; Sergey V Roussakow
Journal:  Mol Clin Oncol       Date:  2017-04-10

5.  A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy.

Authors:  Yuanjue Sun; Yongqian Shu; Baorui Liu; Ping Liu; Changping Wu; Rongsheng Zheng; Xiaohua Zhang; Zhixiang Zhuang; Yongchuan Deng; Leizhen Zheng; Qing Xu; Bin Jiang; Xuenong Ouyang; Jianfei Gao; Nong Xu; Xiaoyi Li; Su Jiang; Chaofan Liang; Yang Yao
Journal:  Exp Ther Med       Date:  2016-11-04       Impact factor: 2.447

6.  Using the Palliative Performance Scale to Estimate Survival for Patients at the End of Life: A Systematic Review of the Literature.

Authors:  Dawon Baik; David Russell; Lizeyka Jordan; Frances Dooley; Kathryn H Bowles; Ruth M Masterson Creber
Journal:  J Palliat Med       Date:  2018-08-21       Impact factor: 2.947

7.  Ischemic stroke and intracranial hemorrhage in patients with recurrent glioblastoma multiforme, treated with bevacizumab.

Authors:  Timo A Auer; Mirjam Renovanz; Federico Marini; Marc A Brockmann; Yasemin Tanyildizi
Journal:  J Neurooncol       Date:  2017-05-29       Impact factor: 4.130

8.  Role functioning is associated with survival in patients with hepatocellular carcinoma.

Authors:  Adam Meier; Adam Yopp; Huram Mok; Pragathi Kandunoori; Jasmin Tiro; Amit G Singal
Journal:  Qual Life Res       Date:  2014-12-13       Impact factor: 4.147

9.  How far along the disease trajectory? An examination of the time-related patient characteristics in the palliative oncology literature.

Authors:  Supakarn Tayjasanant; Eduardo Bruera; David Hui
Journal:  Support Care Cancer       Date:  2016-04-29       Impact factor: 3.603

10.  Meaning in life in patients with advanced cancer: a multinational study.

Authors:  Anna L Gravier; Omar Shamieh; Carlos Eduardo Paiva; Pedro Emilio Perez-Cruz; Mary Ann Muckaden; Minjeong Park; Eduardo Bruera; David Hui
Journal:  Support Care Cancer       Date:  2019-12-19       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.